Carcinoembryonic antigen-related cell adhesion molecule 5
	
		            	Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
| Synonyms/Alias | Carcinoembryonic antigen-related cell adhesion molecule 5 (268-277) | 
| Sequence | QYSWFVNGTF | 
| Areas of Interest | Antigen-presenting Cells; Cancer Research | 
| Source# | Homo sapiens (human) | 
| Epitope | 268-277 | 
| Restricting HLA | HLA-A24 | 
| References | Nukaya; Int J Cancer 1999 | 
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
Required fields are marked with *
×Required fields are marked with *
×If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com